SN-38 is an antineoplastic compound and the active metabolite of irinotecan. It exhibits significantly higher cytotoxic activity than irinotecan itself, with relative potency varying widely in in vitro assays.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 86639-52-3
(3aS,4S,6aR)-4-Methoxytetrahydrofuro[3,4-b]furan-2(3H)-one
pharmaceutical impurity reference standard
(1S)-2,3,4,6-Tetra-O-acetyl-1,5-anhydro-1-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-D-glucitol
pharmaceutical intermediate
OSI 906
active pharmaceutical ingredient
6-Hydroxy-8-[(1R)-1-hydroxy-2-[[2-(4-methoxyphenyl)-1,1-dimethylethyl]amino]ethyl]-2H-1,4-benzoxazin-3(4H)-one
Beta2-adrenergic agonist bronchodilator
10-Hydroxycamptothecin
active pharmaceutical ingredient
TOPOTECAN HYDROCHLORIDE
active pharmaceutical ingredient
Topotecan
active pharmaceutical ingredient
Chimmitecan
antineoplastic agent
(19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione
FJHBVJOVLFPMQE-QFIPXVFZSA-N
CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)O